SCHEMBL5551098

SCHEMBL5551098

CN(C)N(C)C(=O)C1CCCN(Cc2ccccc2)C1

nearest known ligand 0.73

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.73
HTT P42858 3/20 0.67
PKM P14618 1/20 0.67
SMN1; SMN2 Q16637 1/20 0.67
MEN1 O00255 1/20 0.63
KMT2A Q03164 1/20 0.63
ALDH1A1 P00352 4/20 0.60
HPGD P15428 1/20 0.60
CYP2D6 P10635 1/20 0.59
CYP3A4 P08684 2/20 0.58
CYP2C9 P11712 2/20 0.58
CYP1A2 P05177 1/20 0.58
LMNA P02545 1/20 0.57
BCHE P06276 2/20 0.56
POLB P06746 1/20 0.56
ATM Q13315 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
TDP1 Q9NUW8 1/20 0.54
ACHE P22303 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6791438 0.90 KDM4E (0.77) KDM4EHTTPKMSMN1; SMN2MEN1
SCHEMBL6791434 0.90 KDM4E (0.77) KDM4EHTTPKMSMN1; SMN2MEN1
SCHEMBL14697252 0.85 KDM4E (0.70) KDM4EHTTPKMSMN1; SMN2MEN1
SCHEMBL9458519 0.85 HTT (0.89) KDM4EHTTPKMSMN1; SMN2MEN1
Bromide SCHEMBL9458813 0.84 HTT (0.87) KDM4EHTTPKMSMN1; SMN2MEN1
Bromide SCHEMBL9458818 0.84 HTT (0.87) KDM4EHTTPKMSMN1; SMN2MEN1
SCHEMBL23182183 0.82 KDM4E (0.70) KDM4EHTTPKMSMN1; SMN2MEN1
SCHEMBL4512048 0.82 KDM4E (0.70) KDM4EHTTPKMSMN1; SMN2MEN1
SCHEMBL18125935 0.82 ALDH1A1 (0.71) KDM4EHTTPKMSMN1; SMN2MEN1
SCHEMBL3844177 0.82 ALDH1A1 (0.71) KDM4EHTTPKMSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117820204-A Preparation method of R-3-benzyl-3-piperidine formyl trimethylhydrazine 山东百诺医药股份有限公司 2024-04-05 CN disclosed
EP-1768976-A1 CRYSTAL FORMS OF (3R)-1-(2-METHYLALANYL-D-TRYPTOPHYL)-3-(PHENYLMETHYL)-3-PIPERIDINECARBOXYLIC ACID 1,2,2-TRIMETHYLHYDRAZIDE Sapphire Therapeutics, Inc. (US) 2007-04-04 EP disclosed
WO-2006016995-A1 CRYSTAL FORMS OF (3R)-1-(2-METHYLALANYL-D-TRYPTOPHYL)-3-(PHENYLMETHYL)-3-PIPERIDINECARBOXYLIC ACID 1,2,2-TRIMETHYLHYDRAZIDE SAPPHIRE THERAPEUTICS, INC. (US) 2006-02-16 WO disclosed